Biomerica

BMRANasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$11.931 M

$2.60 +3.59%

Close of 21 Sept 2026

Revenue

$4.45M

#3310 by revenue

Earnings

-$3.77M

Loss-making

Shares outstanding

3,090,269

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#12Insight Molecular DiagnosticsIMDX$131.2M
#13ImmucellICCC$92.0M
#14BiomericaBMRA$11.9M
#15VolitionrxVNRX$7.39M
#16Q/C TechnologiesQCLS$6.43M

What if Biomerica were worth as much as…

Open the what-if tool →

Gold $30.3T

$6,597,138

Per share 2,537,361× higher

Bitcoin $1.72T

$374,769.16

Per share 144,142× higher

Nvidia $5.48T

$1,194,137

Per share 459,284× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Biomerica are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.